FR2441627A1 - Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant - Google Patents

Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant

Info

Publication number
FR2441627A1
FR2441627A1 FR7928234A FR7928234A FR2441627A1 FR 2441627 A1 FR2441627 A1 FR 2441627A1 FR 7928234 A FR7928234 A FR 7928234A FR 7928234 A FR7928234 A FR 7928234A FR 2441627 A1 FR2441627 A1 FR 2441627A1
Authority
FR
France
Prior art keywords
imidazolidinediones
polycyclo
pharmaceutical composition
composition containing
novel spiro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7928234A
Other languages
English (en)
Other versions
FR2441627B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2441627A1 publication Critical patent/FR2441627A1/fr
Application granted granted Critical
Publication of FR2441627B1 publication Critical patent/FR2441627B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

L'INVENTION A TRAIT AU DOMAINE DE LA CHIMIE PHARMACEUTIQUE. ELLE CONCERNE DE NOUVELLES SPIRO-POLYCYCLO-IMIDAZOLIDINEDIONES DE FORMULE: (CF DESSIN DANS BOPI) RENFERMANT DANS LEUR STRUCTURE UN NOYAU NAPHTO-A,B EVENTUELLEMENT SUBSTITUE, ANTHRACENO-A,B OU NAPHTO-A,TH, ET LEURS SELS METALLIQUES ACCEPTABLES DU POINT DE VUE PHARMACEUTIQUE. LES COMPOSES DE L'INVENTION SONT UTILES COMME INHIBITEURS D'ALDOSE-REDUCTASE ET COMME AGENTS THERAPEUTIQUES POUR LE TRAITEMENT DES COMPLICATIONS.
FR7928234A 1978-11-16 1979-11-15 Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant Granted FR2441627A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/961,335 US4181728A (en) 1978-11-16 1978-11-16 Spiro-polycyclicimidazolidinedione derivatives

Publications (2)

Publication Number Publication Date
FR2441627A1 true FR2441627A1 (fr) 1980-06-13
FR2441627B1 FR2441627B1 (fr) 1983-06-03

Family

ID=25504341

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7928234A Granted FR2441627A1 (fr) 1978-11-16 1979-11-15 Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant

Country Status (23)

Country Link
US (1) US4181728A (fr)
JP (2) JPS6052157B2 (fr)
AR (1) AR222052A1 (fr)
AT (1) AT369742B (fr)
AU (1) AU515301B2 (fr)
BE (1) BE880065A (fr)
CA (1) CA1125294A (fr)
CH (1) CH642358A5 (fr)
DE (1) DE2946037A1 (fr)
DK (1) DK484479A (fr)
ES (1) ES486007A1 (fr)
FI (1) FI66385C (fr)
FR (1) FR2441627A1 (fr)
GB (1) GB2038315B (fr)
IE (1) IE49116B1 (fr)
IL (1) IL58730A (fr)
IT (1) IT1127231B (fr)
LU (1) LU81890A1 (fr)
NL (1) NL177689C (fr)
PH (1) PH15672A (fr)
PT (1) PT70452A (fr)
SE (1) SE447731B (fr)
YU (1) YU41678B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
EP0065393B1 (fr) * 1981-05-12 1984-12-27 Imperial Chemical Industries Plc Dérivés du pyrrole
IL68314A0 (en) * 1982-04-15 1983-07-31 Alcon Lab Inc Method and composition for inhibiting aldose reductase activity and process for preparing spirofluorofluoren and spiro-difluorofluoren compounds
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
JPS59500618A (ja) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド スピロ―フルオロフルオレン化合物、その製造法およびアルド―スレダクターゼ活性を阻害する組成物
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
DE3342933A1 (de) * 1983-11-26 1985-06-05 Horst G. 5190 Stolberg Schumann Regalfoerderzeug
US4717725A (en) * 1984-04-11 1988-01-05 Alcon Laboratories, Inc. Ophthalmic wound healing with aldose reductase inhibitors
US4600717A (en) * 1984-04-11 1986-07-15 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in ophthalmic wound healing
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
US4576143A (en) * 1984-10-05 1986-03-18 Clark Iii William T Method of immune modification by means of extracorporeal irradiation of the blood
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
US4966911A (en) * 1984-11-20 1990-10-30 Washington Research Foundation Immunoregulatory agents
JPS6372140U (fr) * 1986-10-29 1988-05-14
JPS63119451U (fr) * 1987-01-30 1988-08-02
EP0536119A4 (en) * 1989-02-10 1993-08-04 Washington Research Foundation Immunoregulatory agents

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2683718A (en) * 1952-01-11 1954-07-13 Searle & Co Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione
FR2367754A1 (fr) * 1976-10-18 1978-05-12 Pfizer Nouveaux derives d'hydantoine et composition pharmaceutique les contenant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1032257B (de) * 1954-05-27 1958-06-19 Cutter Lab Verfahren zur Herstellung neuer Hydantoine
GB796069A (en) * 1955-12-23 1958-06-04 Ici Ltd Substituted hydantoins
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4078064A (en) * 1976-08-18 1978-03-07 E. R. Squibb & Sons, Inc. 8H-Pyrazolo[4',3':5,6]pyrido[3,4-e][1,2,4]triazolo[1,5-a]pyrimidines
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2683718A (en) * 1952-01-11 1954-07-13 Searle & Co Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione
FR2367754A1 (fr) * 1976-10-18 1978-05-12 Pfizer Nouveaux derives d'hydantoine et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
AU5288079A (en) 1980-05-22
FR2441627B1 (fr) 1983-06-03
YU277379A (en) 1983-01-21
IL58730A0 (en) 1980-02-29
SE447731B (sv) 1986-12-08
IE792184L (en) 1980-05-16
ES486007A1 (es) 1980-09-01
YU41678B (en) 1987-12-31
DE2946037A1 (de) 1980-05-22
GB2038315A (en) 1980-07-23
PH15672A (en) 1983-03-11
FI66385C (fi) 1984-10-10
AT369742B (de) 1983-01-25
GB2038315B (en) 1982-08-11
IT1127231B (it) 1986-05-21
IT7927311A0 (it) 1979-11-15
SE7909439L (sv) 1980-05-17
NL7908352A (nl) 1980-05-20
AU515301B2 (en) 1981-03-26
LU81890A1 (fr) 1980-06-05
PT70452A (en) 1979-12-01
IL58730A (en) 1984-01-31
IE49116B1 (en) 1985-08-07
AR222052A1 (es) 1981-04-15
NL177689C (nl) 1985-11-01
DK484479A (da) 1980-05-17
FI66385B (fi) 1984-06-29
JPS6144868B2 (fr) 1986-10-04
JPS6052157B2 (ja) 1985-11-18
CA1125294A (fr) 1982-06-08
ATA729779A (de) 1982-06-15
JPS5589268A (en) 1980-07-05
JPS60120870A (ja) 1985-06-28
NL177689B (nl) 1985-06-03
US4181728A (en) 1980-01-01
CH642358A5 (fr) 1984-04-13
FI793586A (fi) 1980-05-17
BE880065A (fr) 1980-05-16

Similar Documents

Publication Publication Date Title
FR2441627A1 (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
FR2415112A1 (fr) Nouveaux derives spirothienohydantoines et composition pharmaceutique les contenant
FR2450832A1 (fr) Nouveaux 3-(1-imidazolylalkyl) indoles, leur procede de production et composition pharmaceutique les contenant
TNSN98036A1 (fr) Derives d'acide hexanoique nouveaux
FR2440371A1 (fr) Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
FR2455027A1 (fr) Esters d'acylcarnitines utiles comme medicaments, leurs procedes de preparation et compositions therapeutiques les contenant
DE2963183D1 (en) 1,4-dihydropyridine compounds, their preparation, pharmaceutical compositions containing said compounds and preparation of these compositions
MA26697A1 (fr) Composes nouveaux inhibiteurs de gsk-3 et compositions pharmaceutiques les contenant
FR2446828A1 (fr) N-benzylimidazoles inhibiteurs selectifs de thromboxanne-synthetase, leur procede de production et compositions pharmaceutiques les contenant
NZ192196A (en) 1-phenyl-2-azolyl-ethanols pharmaceutical compositions
FR2424913A1 (fr) Nouvelles 4-(quinolinylaminobenzoyl) piperazines et composition pharmaceutique les contenant
TNSN98127A1 (fr) Derives d'azetidinylpropylpiperidine , procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2438654A1 (fr) Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose
TNSN98185A1 (fr) Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2402640A1 (fr) Nouveaux phenols a substituant hydroxyalkyle ou oxoalkyle et composition pharmaceutique les contenant
HUP9801991A2 (hu) Humán leukocita-elasztáz inhibítorokként felhasználható prolinszármazékok
TNSN99013A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2424908A1 (fr) Nouveaux analogues de prostacycline, leur procede de production et medicament les contenant
FR2417502A1 (fr) Nouvelles 2-phenylimino-imidazolidines substituees, leurs sels d'addition avec des acides, medicaments les renfermant et procedes pour leur preparation
FR2432520A1 (fr) Nouvelles imidazoquinoxalines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
FR2446819A1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
BE878020A (fr) Derives n-substitues de l'acide aziridine-2-carboxylique immunostimulateurs, procedes de preparation et compositions pharmaceutiques les contenant
FR2506766A1 (fr) Sel de l-lysine ou de dl-lysine de l'acide 5-(p-chlorobenzoyl)-1,4-dimethylpyrrole-2-acetique, son procede de preparation et composition analgesique le contenant
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension

Legal Events

Date Code Title Description
ST Notification of lapse